Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2016-01-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-150750PMID 26757188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease

  2015cited by this paper
• Understanding the Beneficial and Detrimental Effects of Donepezil and Rivastigmine to Improve their Therapeutic Value

  2015cited by this paper
• Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease

  2014cited by this paper
• Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort

  2014cited by this paper
• Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease.

  2013influential reference
• APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study

  2013cited by this paper
• Butyrylcholinesterase genotype and gender influence Alzheimer's disease phenotype

  2013cited by this paper
• Variant of TREM2 associated with the risk of Alzheimer's disease.

  2013cited by this paper
• Apolipoprotein ε4 Modulates Phenotype of Butyrylcholinesterase in CSF of Patients with Alzheimer's Disease

  2012cited by this paper
• The cholinergic system and Parkinson disease.

  2011cited by this paper
• Center

  2011cited by this paper
• Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

  2009cited by this paper
• Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

  2009cited by this paper
• BuChE‐K and APOE ϵ4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline

  2009cited by this paper
• Emerging hypotheses regarding the influences of butyrylcholinesterase-K variant, APOE epsilon 4, and hyperhomocysteinemia in neurodegenerative dementias.

  2009cited by this paper
• Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.

  2008cited by this paper
• APOE ε4 lowers age at onset and is a high risk factor for Alzheimer's disease; A case control study from central Norway

  2008cited by this paper
• Frequency and Case Identification of Dementia with Lewy Bodies Using the Revised Consensus Criteria

  2008cited by this paper
• Synergistic effect of apolipoprotein E ϵ4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease

  2008cited by this paper
• Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.M400486-JLR200

  2005cited by this paper
• Rate of progression of cognitive decline in Alzheimer’s disease: effect of butyrylcholinesterase K gene variation

  2005cited by this paper
• Interaction between CYP19 Aromatase and Butyrylcholinesterase Genes Increases Alzheimer’s Disease Risk

  2005cited by this paper
• The K Variant of the Butyrylcholinesterase Gene Is Associated with Reduced Phosphorylation of Tau in Dementia Patients

  2005cited by this paper
• Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.

  2004cited by this paper
• Neurobiology of butyrylcholinesterase

  2003cited by this paper
• Regulation of attention and response to therapy in dementia by butyrylcholinesterase.

  2003cited by this paper
• Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E ε4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology

  2000cited by this paper
• Dementia, quantitative neuroimaging, and apolipoprotein E genotype.

  2000cited by this paper
• The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer's disease in women

  2000cited by this paper
• Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease

  2000cited by this paper
• Evaluation of polymorphisms in the presenilin-1 gene and the butyrylcholinesterase gene as risk factors in sporadic Alzheimer's disease

  1999cited by this paper
• Butyrylcholinesterase K variant and Alzheimer’s disease

  1999cited by this paper
• Further evidence for a synergistic association between APOE epsilon4 and BCHE-K in confirmed Alzheimer's disease.

  1999cited by this paper
• Further evidence for a synergistic association between APOEɛ4 and BCHE-K in confirmed Alzheimer’s disease

  1999cited by this paper
• Evidence that the butyryl-cholinesterase K variant can protect against late-onset Alzheimer's disease

  1999cited by this paper
• Butyrylcholinesterase K: an association with dementia with Lewy bodies.

  1998cited by this paper
• Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

  1998cited by this paper
• Association between apolipoprotein E ε4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia

  1998cited by this paper
• Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.

  1998cited by this paper
• Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease.

  1997cited by this paper
• DNA mutation associated with the human butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites.

  1992cited by this paper
• The cloned butyrylcholinesterase (BCHE) gene maps to a single chromosome site, 3q26.

  1991cited by this paper
• Proposed nomenclature for human butyrylcholinesterase genetic variants identified by DNA sequencing

  1991cited by this paper
• Phenotypic and molecular biological analysis of human butyrylcholinesterase variants.

  1990cited by this paper
• Isolation and characterization of full-length cDNA clones coding for cholinesterase from fetal human tissues.

  1987cited by this paper
• The biology of cholinesterases

  1974cited by this paper

• Apolipoprotein E Gene in α-Synucleinopathies: A Narrative Review

  2024cites this paper
• Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2023cites this paper
• Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease

  2021cites this paper
• Delft University of Technology Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies

  2021cites this paper
• Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies

  2021cites this paper
• Genetic Architecture and Molecular, Imaging and Prodromic Markers in Dementia with Lewy Bodies: State of the Art, Opportunities and Challenges

  2021cites this paper
• Genetic variants and oxidative stress in Alzheimer's disease.

  2020cites this paper
• Systematic review of genetic association studies in people with Lewy body dementia

  2020influential citation
• Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer’s Disease in a Prospective Cohort Study

  2020cites this paper
• Anti-inflammatories in Alzheimer’s disease—potential therapy or spurious correlate?

  2020cites this paper
• Diagnoses of pathological states based on acetylcholinesterase and butyrylcholinesterase.

  2019cites this paper
• The Associations Between Cognitive Prognosis and Kynurenines Are Modified by the Apolipoprotein ε4 Allele Variant in Patients With Dementia

  2019cites this paper
• Association of butyrocholinesterase Gene K variant with postoperative delirium in Chinese elderly patients after noncardiac surgery

  2018cites this paper
• An update on the genetics of dementia with Lewy bodies.

  2017cites this paper
• The prognosis of dementia with Lewy bodies.

  2017cites this paper
• Plasma butyrylcholinesterase activity: a possible biomarker for differential diagnosis between Alzheimer's disease and dementia with Lewy bodies?

  2017cites this paper
• Revisiting the genetics of APOE

  2017cites this paper
• Effect of Vascular Risk Factors on the Progression of Mild Alzheimer’s Disease and Lewy Body Dementia

  2016cites this paper